These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 35326)

  • 1. Uptake and excretion of benzo[a]pyrene and its metabolites by the rat pancreas.
    Iqbal ZM; Yoshida A; Epstein SS
    Drug Metab Dispos; 1979; 7(1):44-8. PubMed ID: 35326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic metabolism of benzo(a)pyrene in vitro and in vivo in the Long-Evans rat.
    Black O; Murrill E; Pallas F
    Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):291-307. PubMed ID: 7414050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fate of radioactive exocrine pancreatic proteins injected into the blood circulation of the rat. Tissue uptake and transepithelial excretion.
    Rohr G; Scheele G
    Gastroenterology; 1983 Nov; 85(5):991-1002. PubMed ID: 6618114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of benzo(a)pyrene by guinea pig pancreatic microsomes.
    Iqbal ZM; Varnes ME; Yoshida A; Epstein SS
    Cancer Res; 1977 Apr; 37(4):1011-5. PubMed ID: 844037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic excretion of benzo(a)pyrene in the control and microsomally induced rat: the influence of plasma lipoproteins and albumin as carrier molecules.
    Shu HP; Bymun EN
    Cancer Res; 1983 Feb; 43(2):485-90. PubMed ID: 6293698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism and enterohepatic circulation of benzo(a)pyrene-4,5-epoxide in the rat.
    Elmhirst TR; Chipman JK; Ribeiro O; Hirom PC; Millburn P
    Xenobiotica; 1985 Nov; 15(11):899-906. PubMed ID: 4082630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of [3H]-methylcholanthrene in the perfused rat liver.
    Takahashi G; Shah H; Weinhouse S
    Cancer Res; 1977 Feb; 37(2):369-75. PubMed ID: 188544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of uptake and biliary excretion of benzo(alpha)pyrene and mutagenic metabolites in isolated perfused rat liver.
    Forti GC; Trieff NM
    Teratog Carcinog Mutagen; 1980; 1(3):269-82. PubMed ID: 6119817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total body clearance of circulating benzo(a)pyrene in conscious rats: effect of pretreatment with 3-methylcholanthrene and the role of liver and lung.
    Wiersma DA; Roth RA
    J Pharmacol Exp Ther; 1983 Sep; 226(3):661-7. PubMed ID: 6310077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and biliary excretion of benzo[a]pyrene 4,5-oxide in the rat.
    Plummer JL; Smith BR; Ball LM; Bend JR
    Drug Metab Dispos; 1980; 8(2):68-72. PubMed ID: 6103790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fate of intratracheally installed benzo(a)pyrene in the isolated perfused rat lung of both control and 20-methylcholanthrene pretreated rats.
    Vainio H; Uotila P; Hartiala J; Pelkonen O
    Res Commun Chem Pathol Pharmacol; 1976 Feb; 13(2):259-71. PubMed ID: 1257613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of bile salts on rates of formation, accumulation, and export of mutagenic metabolites from benzo(a)pyrene produced by the perfused rat liver.
    Kari FW; Kauffman FC; Thurman RG
    Cancer Res; 1985 Apr; 45(4):1621-7. PubMed ID: 3978630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzo(a)pyrene disposition and metabolism in rats following intratracheal instillation.
    Weyand EH; Bevan DR
    Cancer Res; 1986 Nov; 46(11):5655-61. PubMed ID: 3756912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between benzo(a)pyrene-induced DNA base modification and frequency of reverse mutations in mutant strains of Salmonella typhimurium.
    Fahl WE; Scarpelli DG; Gill K
    Cancer Res; 1981 Sep; 41(9 Pt 1):3400-6. PubMed ID: 6266655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolism of benzo(alpha)pyrene in isolated rat liver cells.
    Vadi H; Moldéus P; Capdevila J; Orrenius S
    Cancer Res; 1975 Aug; 35(8):2083-91. PubMed ID: 1149022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of benzo(a)pyrene metabolite:DNA adducts in lung and liver of mice.
    Kulkarni MS; Anderson MW
    Cancer Res; 1984 Jan; 44(1):97-101. PubMed ID: 6317174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of 3-methylcholanthrene in rat pancreas.
    Black O; Murrill E; Fanska C
    Dig Dis Sci; 1981 Apr; 26(4):358-63. PubMed ID: 6263566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of mutagenic glucuronide formation from benzo(a)pyrene in the nonrecirculating perfused rat liver.
    Kari FW; Kauffman FC; Thurman RG
    Cancer Res; 1984 Nov; 44(11):5073-8. PubMed ID: 6488167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biliary excretion, systemic availability and reactivity of metabolites following intraportal infusion of [3H]benzo[a]pyrene in the rat.
    Chipman JK; Frost GS; Hirom PC; Millburn P
    Carcinogenesis; 1981; 2(8):741-5. PubMed ID: 6269773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biliary excretion of 3,4-benzpyrene in nafenopin-treated rats.
    Levine WG; Bognacki J
    J Pharmacol Exp Ther; 1976 Feb; 196(2):486-92. PubMed ID: 1255492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.